Supernus Pharmaceuticals, Inc.
STABILIZED FORMULATIONS OF CNS COMPOUNDS

Last updated:

Abstract:

Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.

Status:
Application
Type:

Utility

Filling date:

25 Jun 2021

Issue date:

21 Oct 2021